Table 5.

Comparison between the A. hydrophila group and the K. pneumoniae group for characteristics at the first consultation and treatment

Variable	A. hydrophila group	K. pneumoniae group	p value
Patients, n	11	7
Age, years	65.9 ± 11.4	59.9 ± 19.6	0.42
Sex, n
Male	9	6	0.47
Female	2	1
Mortality rate, %	45.5	42.8	0.65
Death	5	3
Survival	6	4
Timing from contact to presentation to the ER, days	1.55 ± 0.52	5.14 ± 2.12	<0.001a
Death	1.6 ± 0.55	4.33 ± 2.52	0.049a
Survival	1.5 ± 0.55	5.75 ± 1.89	0.0007a
Timing from the first consultation to the first operation, h	5.91 ± 5.1	7.43 ± 4.04	0.52
Death	7.43 ± 6.77	5 ± 2	0.58
Survival	4.67 ± 3.33	9.25 ± 4.43	0.097
Underlying chronic disease, n
Hepatic dysfunction and DM	2 (1)	3 (0)
Hepatic dysfunction with or without other conditions	4 (4)	0 (0)	0.048b
Diabetes mellitus with or without other conditions	2 (0)	4 (3)	0.01c
End-stage renal disease	1 (0)	0 (0)
Hypertension	1 (0)	0 (0)
Gout	1 (0)	0 (0)
Wound location, n
Upper extremity	2 (0)	3 (1)
Lower extremity	9 (5)	4 (2)
Hospital stay, days	24.6 ± 28.3	26.3 ± 18.8	0.89
Death	6.20 ± 5.76	27.7 ± 27.4	0.13
Survival	40 ± 30.8	25.2 ± 14.2	0.4

Values are presented as means ± SD unless otherwise stated. Values in parentheses represent the number of deaths.

^aMean p < 0.05 and the difference was significant.

^bMean p < 0.05 and the difference was significant (association with mortality for hepatic dysfunction with or without other conditions, e.g. diabetes, gout, or steroid use).

^cMean p < 0.05 and the difference was significant (association with diabetes mellitus with or without other conditions).